Trial Details

Not Recruiting
Basic Information
Clinical ID c4902
Identifier JPRN-UMIN000019958
Trial Title Research for biomarkers of inflammatory bowel disease. - Investigation of the usefulness of LRG for evaluation of disease condition after adalimumab treatments - Investigation of the usefulness of LRG for evaluation of disease condition after adalimumab
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Crohn's disease, ulcerative colitis
Interventions Patients with Crohn's disease or ulcerative colitis Adalimumab administration subcutaneously for 52 weeks using the recommended dosing regimens.
Participant Information
Sponsor Iwate Medical University Kochi Medical School Hospital Keio University School of Medicine
City NULL
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL